Alexis Bingham

Alexis Bingham is an experienced professional in the aesthetics industry, currently serving as Aesthetics Business Manager at Galderma since August 2024. Previously held roles include Senior Sales Consultant at CLINICAL SKIN and Business Development Manager - Aesthetics at RVL Pharmaceuticals, where Alexis successfully launched UPNEEQ®, the first FDA-approved treatment for acquired blepharoptosis in adults. Earlier experience includes positions as Aesthetic Business Manager at Endo Aesthetics, Sr. Manager of Marketing at Suneva Medical, and Business Development Manager at USDM Life Sciences, focusing on performance and compliance in life sciences organizations. Bingham's career began at Mentor Worldwide, LLC, part of Johnson & Johnson, where roles ranged from Online Marketing Coordinator to Product Director in Digital Marketing. Alexis holds a BA in Journalism from San Diego State University, earned between 2001 and 2005.